CD40 and Lymphadenopathy: As show in the figure 6A, B, agonistic anti-CD40 mAb treatment induced lymphadenopathy and splenomegaly as determined by volume and weight, while CD40 ×HER2 bsAb did not cause any changes in the shape and conformation of spleen.